Webpackaging logo

Schreiner Medipharm develops innovative label with self-lifting starter tab for small vials

  • Schreiner MediPharm
Europe, Germany, Austria, Germany, Asia, East Asia, China, Health, Pharmaceuticals, Primary Packaging, Secondary Packaging, Labels, Coating, Labelling, Sleeving, Label, Sleeve Design, Printing

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has introduced a new version of its Pharma-Comb SL (Self-Lifting) label with a special starter tab.  Originally developed for a leading producer of anesthetics in China, the special label design is particularly easy to use on small vials, allowing efficient and reliable marking of medication while simultaneously increasing patient safety.

Pharma-Comb labels are specialty labels with one or several detachable parts on which important data is printed to make this information transferable.  The small vial size posed a special challenge for the new version of the Pharma-Comb SL label.  Despite minimal space, the label must contain all pertinent product information, provide room for variable post-printing, and integrate a detachable part to mark a disposable syringe once the anesthetic is drawn from the vial.

This newly developed solution is based on a three-layered film label. The outer layer offers ample space for important product information and post-printing with batch number and expiration date. When opening the outer layer, which tightly wraps around a small vial, the detachable part underneath is exposed. Due to its special design, the starter tab of the detachable label part is self-lifting. As a result, the physician or nurse can easily peel it off –even with gloves on – and mark the syringe after drawing medication from the vial. This detachable label contains information including product name and active ingredients, and also has two fields for entering the dosage, date and time of administration, and the initials of the physician or nurse. Thanks to a useful varnish coating, the detachable label can be inscribed by hand in pen or pencil.

“In hospitals or other healthcare settings, medication errors can have severe patient consequences, making clear, reliable marking of administered medicines extremely important, especially in refilling processes,” said Gene Dul, President of Schreiner MediPharm U.S. “Labels with detachable parts can make an important contribution here, as they reliably mark disposable syringes once a dose is drawn. The self-lifting starter tab incorporated into our latest Pharma-Comb SL label allows this task to be performed simply and conveniently.”

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Innovation
  • English
  • Modified 17 Oct 2016
  • Hits 1818